Kinfo
Sintx Technologies Inc. logo

Sintx Technologies Inc.

SINTNASDAQHealthcare·US · USD
$1.89
-0.03 (-1.56%)
Close · 2026-06-29

Price

Key statistics

Valuation
Market cap12.02M USD
Enterprise value9.67M USD
Trailing P/E-0.30
Forward P/E-1.34
PEG ratio0.01
Price / sales11.86
Price / book8.77
Profitability
Gross margin21.33%
Operating margin-830.00%
Profit margin23.59%
Return on assets-73.90%
Return on equity-311.41%
Income (TTM)
Revenue1.03M USD
Gross profit482.00K USD
EBITDA-11.07M USD
Net income-17.61M USD
Diluted EPS-$5.57
Rev. growth (YoY)3.00%
Balance sheet
Total cash1.89M USD
Total debt3.26M USD
Debt / equity360.95
Current ratio1.04
Book value / share$0.22
Cash flow (TTM)
Operating cash flow-9.76M USD
Levered free cash flow-3.70M USD
Shares & price
Shares outstanding4.12M
Float3.44M
Held by institutions10.24%
Beta0.62
50-day MA$2.27
200-day MA$3.15
52-week high$6.78
52-week low$1.80
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-06-090.480.22−54.17%2026-05-15-0.66-0.70−6.06%2026-03-02-0.54-0.70−29.63%
About Sintx Technologies Inc.

Sintx Technologies Inc. is an advanced ceramics company specializing in the research, development, and commercialization of silicon nitride-based medical devices and biomaterials. It manufactures solid and porous silicon nitride products, silicon nitride powder, coatings, and composite materials including polyether ether ketone and polyetherketoneketone for biomedical, technical, and antipathogenic applications. The company offers innovative solutions such as the FDA-cleared SINAPTIC Foot & Ankle Osteotomy Wedge System and OsseoSculpt biologic, which feature pro-osteogenic, bacteriostatic, and enhanced imaging properties. Sintx Technologies Inc. also develops antipathogenic fibrous materials and fabrics for medical textiles, wound dressings, filtration, PPE, and high-touch surfaces, supported by composition and method patents. Recent advancements include the SiN/PEEK compound produced via partnerships for AI-assisted, 3D-printed patient-specific implants targeting orthopedic, spine, and reconstructive surgery markets. Founded in 1996 and headquartered in Salt Lake City, Utah, Sintx Technologies Inc. focuses on infection-resistant devices, polymer composites, and licensing opportunities in the medical device sector.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Eric K. Olson
Employees
32
Headquarters
Salt Lake City, UT, United States

Frequently asked questions about Sintx Technologies Inc.